Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis

Abstract

Atherosclerosis can be regarded as a chronic inflammatory state, in which macrophages play different and important roles. Phagocytic proinflammatory cells populate growing atherosclerotic lesions, where they actively participate in cholesterol accumulation. Moreover, macrophages promote formation of complicated and unstable plaques by maintaining proinflammatory microenvironment. At the same time, anti-inflammatory macrophages contribute to tissue repair and remodelling and plaque stabilization. Macrophages therefore represent attractive targets for development of antiatherosclerotic therapy, which can aim to reduce monocyte recruitment to the lesion site, inhibit proinflammatory macrophages, or stimulate anti-inflammatory responses and cholesterol efflux. More studies are needed, however, to create a comprehensive classification of different macrophage phenotypes and to define their roles in the pathogenesis of atherosclerosis. In this review, we provide an overview of the current knowledge on macrophage diversity, activation, and plasticity in atherosclerosis and describe macrophage-based cellular tests for evaluation of potential antiatherosclerotic substances.

Unified nexus of macrophages and maresins in cardiac reparative mechanisms

“…Macrophages in atherosclerotic lesions actively participate in lipoprotein ingestion, and their accumulation gives rise to the formation of foam cells filled with lipid droplets (Table 1) (84). Accumulation of foam cells in the lesions results in lipid storage and growth of atherosclerotic plaque.…”

Antibody‐Based Tracers for PET/SPECT Imaging of Chronic Inflammatory Diseases

“…Aside from autoimmune diseases, MMR has been investigated as a target for atherosclerosis because it is known that macrophages also play an important role in the formation of vulnerable plaques and foam cells in atherosclerosis . For example, M1 macrophages (pro‐inflammatory macrophages) are involved in lipid accumulation and inflammatory responses, while M2 macrophages (alternatively activated macrophages) are associated with plaque stabilization and inflammation resolution . Varasteh et al.…”

Recent Advances in Managing Atherosclerosis via Nanomedicine

“…In response, these endothelial cells express more pro‐inflammatory chemokines and adhesion molecules, and are more susceptible to monocyte adhesion . Circulating lipoproteins are more likely to penetrate the arterial wall and accumulate in the subendothelial proteoglycan‐rich layer within the intima . VCAM‐1 is the most common biomarker targeted by bio‐nanomaterials for delivery to atherosclerotic plaques (Table S1, Supporting Information) .…”